Asia Pacific Eubiotics Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

The Asia-Pacific Eubiotics market has been segmented by type into probiotics, prebiotics, organic acids, and essential oils among others. Also, more than five demographics have been covered in the scope of the study.

APAC Eubiotics Market Size

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:
View Global Report
Asia-Pacific Eubiotics Market Growth
Study Period 2019 - 2029
Base Year For Estimation 2023
Forecast Data Period 2024 - 2029
Historical Data Period 2019 - 2022
CAGR 5.80 %
Market Concentration High

Major Players

Asia-Pacific Eubiotics Market Key Players

*Disclaimer: Major Players sorted in no particular order

Need a report that reflects how COVID-19 has impacted this market and its growth?

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

APAC Eubiotics Market Analysis

The Asia-Pacific feed probiotics market was valued at USD 885.2 million in 2019 and is projected to witness a CAGR of 7.4% over the forecast period. Development of research programs by local and global players are the major factors that are driving the growth of the market. Provita Eurotech Ltd, Life Products, Inc., Calpis Co. Ltd, Chr. Hansen A/S and Lallemand, Inc. are some of the major players operating in the market. Studies showed that Probiotics have enhanced the growth rate in broilers better than AGP (avilamycin) and other substitutes for AGP, such as phytochemicals, such as essential oils. Thus, increasing awareness pertaining to the nutritional benefits of probiotics is likely to further drive the Eubiotics market during the forecast period.

APAC Eubiotics Market Trends

This section covers the major market trends shaping the APAC Eubiotics Market according to our research experts:

Yeast Derived Probiotic Supplemets to Drive the Eubiotics Market Growth

Yeast Probiotic fraction supplements have become a key focus area in improving gut functions at various levels such as intestinal microbiota stabilization, gut integrity improvement, and natural defense modulation. The ongoing field trials also highlighted the positive impact of yeast probiotics on the lactation phase of cattle, and swine alongside evidence of reduced treatment costs in livestock farming. As of March 2020, a field trial was conducted in concern with Bovine Respiratory Disease(BRD). A ban on antibiotics has promoted the alternative methods of research to treat this BRD. At a dosage rate of 5 grams per head per day, a cattle feedlot of 120 in total was treated with Actisaf Sc 47 and Safmannan, a yeast probiotic solution developed by Phileo Lesaffre Animal Care. The trial results signified the improved performance in terms of body weight by 1.5% and recovery from the morbidity and significantly reduced the treatment cost by 53.4%. Another field trial made by Lallemand as of February 2020, mentioned the improved performance of hyper prolific sows when treated with probiotic yeast, S. c. boulardii. Thus, innovating such novel solutions to enhance the cattle performance can be treated as a potential opportunity to find sustainable alternatives for antibiotics to improve animal performance in the years to come.

Asia-Pacific Eubiotics Market Size

China to Dominate the Eubiotics Market

China is one of the major players in the global feed probiotics industry, contributing around 50.80% revenue share in the Asia-Pacific probiotics market. The production of Eubiotics, especially probiotics for the aquaculture industry is a thriving sector in China. Lactobacillus is the most common variant of probiotic bacteria used in the aquafeed industry in China. Owing to the African Swine Fever (ASF) outbreaks in China, the pig herds reduced significantly in 2018. Slow herd replenishment, especially in the swine fever affected regions, is contributing to the near time shortfall and resulting in a decrease in swine feed in China. The aforementioned trends vividly claim that the probiotics industry in China to be profoundly characterized by strong R&D investments focusing on product and regional expansion. Moreover, the increasing regulations, for instance, strict norms by the EU Commission and Food and Drug Administration(FDA), pertaining to the use of antibiotics in the feed industry is likely to further boost the feed Eubiotics market, over the forecast period in China.

Asia-Pacific Eubiotics Market Share

APAC Eubiotics Industry Overview

The market studied is highly fragmented and is dominated by Chr. Hansen A/S, DuPont de Nemours Inc., Koninklijke DSM NV, and Bluestar Adisseo Company. DuPont de Nemours Inc. and Chr. Hansen A/S, being the market leaders, cater to a wider range of product offerings and have a strong geographical presence, providing a competitive advantage in the market. The continuous growth in the revenue generation is further assisting the market's growth. The market leaders, such as Chr. Hansen, are offering a wider range of feed probiotics, including BIOPLUS® YC, GALLIPRO®, GALLIPRO® Tect, and BOVAMINE® Dairy, catering to a surplus range of animals, including the swine, poultry, and dairy industries. Moreover, the company accounted for 22% of the share of the Health and Nutrition sector in 2018.

APAC Eubiotics Market Leaders

  1. DSM Nutritional Products, Inc.

  2. Novus International, Inc.

  3. Kemin Industries

  4. Bluestar Adisseo Company

  5. Lallemand, Inc.

*Disclaimer: Major Players sorted in no particular order

DSM Nutritional Products, Inc., Novus International, Inc., Kemin Industries, Bluestar Adisseo Company, Lallemand, Inc.
Need More Details on Market Players and Competitors?
Download PDF

APAC Eubiotics Market Report - Table of Contents

1. INTRODUCTION

  • 1.1 Study Deliverables
  • 1.2 Study Assumptions & Scope of the Study

2. RESEARCH METHODOLOGY

3. EXECUTIVE SUMMARY

4. MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
  • 4.3 Market Restraints
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Bargaining Powers of Buyers
    • 4.4.2 Bargaining Powers of Suppliers
    • 4.4.3 Threat of New Entrants
    • 4.4.4 Threat of Substitutes
    • 4.4.5 Competitive Rivalry

5. MARKET SEGMENTATION

  • 5.1 Type
    • 5.1.1 Probiotics
    • 5.1.1.1 Lactobacilli
    • 5.1.1.2 Bifidobacteria
    • 5.1.1.3 Other Probiotics
    • 5.1.2 Prebiotics
    • 5.1.2.1 Inulin
    • 5.1.2.2 Fructo-Oligosaccharides
    • 5.1.2.3 Galacto-Oligosaccharides
    • 5.1.2.4 Other Prebiotics
    • 5.1.3 Organic Acids
    • 5.1.4 Essential Oils
  • 5.2 Geography
    • 5.2.1 Asia-Pacific
    • 5.2.1.1 China
    • 5.2.1.2 India
    • 5.2.1.3 Indonesia
    • 5.2.1.4 Thailand
    • 5.2.1.5 Japan
    • 5.2.1.6 South Korea
    • 5.2.1.7 Australia
    • 5.2.1.8 Rest of Asia-Pacific

6. COMPETITIVE LANDSCAPE

  • 6.1 Most Adopted Strategies
  • 6.2 Market Share Analysis
  • 6.3 Company Profiles
    • 6.3.1 Life Products, Inc
    • 6.3.2 Calpis Co. Ltd
    • 6.3.3 Chr. Hansen A/S
    • 6.3.4 Lallemand, Inc.
    • 6.3.5 Danisco A/S
    • 6.3.6 DSM Nutritional Products, Inc.
    • 6.3.7 Orffa International Holding B.V.
    • 6.3.8 Novus International, Inc.
    • 6.3.9 Kemin Industries, Inc.
    • 6.3.10 Biovet Joint Stock Company
    • 6.3.11 Biomin Holding GmbH
    • 6.3.12 Bluestar Adisseo Company
  • *List Not Exhaustive

7. MARKET OPPORTUNITIES AND FUTURE TRENDS

8. IMPACT OF COVID-19

** Subject To Availablity
You Can Purchase Parts Of This Report. Check Out Prices For Specific Sections
Get Price Break-up Now

APAC Eubiotics Industry Segmentation

Feed Eubiotics are considered to be the commercially-manufactured feed additive products that are used to enhance the characteristics such as weight gain, feed conversion ratio, and feed intake when fed in appropriate proportions. The feed Eubiotics that is accounted for in the commercial compound feed production has only been considered in the scope of the study.

Type Probiotics Lactobacilli
Bifidobacteria
Other Probiotics
Type Prebiotics Inulin
Fructo-Oligosaccharides
Galacto-Oligosaccharides
Other Prebiotics
Type Organic Acids
Essential Oils
Geography Asia-Pacific China
India
Indonesia
Thailand
Japan
South Korea
Australia
Rest of Asia-Pacific
Need A Different Region Or Segment?
Customize Now

APAC Eubiotics Market Research FAQs

The Asia Pacific Eubiotics Market is projected to register a CAGR of 5.80% during the forecast period (2024-2029)

DSM Nutritional Products, Inc., Novus International, Inc., Kemin Industries, Bluestar Adisseo Company and Lallemand, Inc. are the major companies operating in the Asia Pacific Eubiotics Market.

The report covers the Asia Pacific Eubiotics Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Asia Pacific Eubiotics Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029.

Asia Pacific Eubiotics Industry Report

Statistics for the 2024 Asia Pacific Eubiotics market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Asia Pacific Eubiotics analysis includes a market forecast outlook to 2029 and historical overview. Get a sample of this industry analysis as a free report PDF download.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!

Asia Pacific Eubiotics Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)